Cardiac MRI scans are delivering more and more value as time goes on, in part thanks to the continued rise of AI. 

Certain lots of argatroban, a blood thinner often used as an alternative to heparin during PCI, have been recalled due to the presence of particulate matter. The affected products should not be used to treat any patients due to an increased risk of adverse events.

The recent PRO-TAVI trial showed that care teams can safely perform PCI at a later date when patients undergoing TAVR present with concomitant coronary artery disease. According to this latest analysis, however, there may still be certain patients who benefit from undergoing PCI prior to TAVR.

The rise of CCTA continues to be one of modern medicine's biggest stories. An upcoming webinar will explore what cardiologists, executives and other stakeholders need to know about building and growing a productive CCTA program in 2026 and beyond.

Steroid users can undo at least some of the damage if they simply stop taking them. 

Traditionally, the interventional cardiologist first visualizes the coronary anatomy in detail when contrast is injected in the catheterization laboratory. For many patients, however, that anatomy has already been captured, often in considerable detail, by coronary CT angiography (CCTA) performed earlier in the clinical pathway. This article considers how this dataset can be used to plan the procedure, an approach referred to as CT-guided PCI.

Rick Snyder, MD, president of the Cardiac PET Alliance, says PET offers better images than SPECT and is associated with much less radiation.

William Holding, a veteran healthcare consultant, spoke to Cardiovascular Business about the ever-changing cardiology industry. Should private practices seek a deal or stay independent? How has private equity impacted the market? He answered those questions and many more. 

The ACC, SCAI and STS have shared early support for expanding Medicare coverage to include TAVR in patients with native AR. The groups emphasized that CED requirements and multidisciplinary heart team meetings are necessary to ensure patients receive the best possible care going forward.

“Our analyses could not fully ascribe the effects of semaglutide on cardiovascular disease to known risk factors with any certainty,” one researcher said after exploring years of data. "These results suggest that semaglutide should be considered as a cardiovascular disease reduction drug and not just as a weight loss drug." 

AI-based tools are here to stay, but one expert does not see them replacing cardiologists anytime soon. Look at recent trends in radiology, he says, to get a better idea of what cardiology's future may look like.

In addition, higher doses of oral HRT may slightly increase a woman's risk of experiencing a heart attack or stroke. 

New survey results, published in Insights Into Imaging, explore global knowledge, attitudes and practices related to contrast media sustainability,

A lack of generalizability in the early days of AI development was one of the biggest caveats attached to the technology.